Small Percentage of Adults with Early Alzheimer’s Eligible for Leqembi: Study | BioSpace
https://www.biospace.com/article/sm...arly-alzheimer-s-eligible-for-leqembi-study-/
The Mayo Clinic collected data from 237 individuals between the ages of 50 and 90 years of age with mild dementia and evidence of amyloid-ß plaque deposits in the brain. The research, published recently in the journal Neurology, indicates that only a small percentage of individuals with early Alzheimer’s meet the criteria for clinical trial inclusion.
At the same time, researchers found that after the exclusions—including stroke, cardiovascular disease, a history of cancer, and brain scan findings that showed abnormalities like old, small brain bleeds or brain injuries due to insufficient blood supply—only 19 people, or 8%, would have been eligible for a trial.
https://www.biospace.com/article/sm...arly-alzheimer-s-eligible-for-leqembi-study-/
The Mayo Clinic collected data from 237 individuals between the ages of 50 and 90 years of age with mild dementia and evidence of amyloid-ß plaque deposits in the brain. The research, published recently in the journal Neurology, indicates that only a small percentage of individuals with early Alzheimer’s meet the criteria for clinical trial inclusion.
At the same time, researchers found that after the exclusions—including stroke, cardiovascular disease, a history of cancer, and brain scan findings that showed abnormalities like old, small brain bleeds or brain injuries due to insufficient blood supply—only 19 people, or 8%, would have been eligible for a trial.